Xenetic Biosciences Statistics Share Statistics Xenetic Biosciences has 320.69K
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 320.69K Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 0.01% Shares Floating n/a Failed to Deliver (FTD) Shares 1 FTD / Avg. Volume 0.16%
Short Selling Information The latest short interest is 1, so 0% of the outstanding
shares have been sold short.
Short Interest 1 Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.55 and the forward
PE ratio is null.
Xenetic Biosciences's PEG ratio is
0.3.
PE Ratio -1.55 Forward PE n/a PS Ratio 2.46 Forward PS n/a PB Ratio 1.02 P/FCF Ratio -2.18 PEG Ratio 0.3
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Xenetic Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.37,
with a Debt / Equity ratio of 0.
Current Ratio 7.37 Quick Ratio 7.37 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $625.07K Profits Per Employee $-990.07K Employee Count 4 Asset Turnover 0.36 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 2.3, so Xenetic Biosciences's
price volatility has been higher than the market average.
Beta 2.3 52-Week Price Change n/a 50-Day Moving Average 12.44 200-Day Moving Average 9.07 Relative Strength Index (RSI) 63.35 Average Volume (20 Days) 635
Income Statement In the last 12 months, Xenetic Biosciences had revenue of 2.5M
and earned -3.96M
in profits. Earnings per share was -2.57.
Revenue 2.5M Gross Profit 2.5M Operating Income -4.2M Net Income -3.96M EBITDA -4.2M EBIT -4.2M Earnings Per Share (EPS) -2.57
Full Income Statement Balance Sheet The company has 6.17M in cash and 0 in
debt, giving a net cash position of 6.17M.
Cash & Cash Equivalents 6.17M Total Debt n/a Net Cash n/a Retained Earnings -197.19M Total Assets 5.79M Working Capital 4.81M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -2.82M
and capital expenditures 0, giving a free cash flow of -2.82M.
Operating Cash Flow -2.82M Capital Expenditures n/a Free Cash Flow -2.82M FCF Per Share -1.83
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -168.16% and -158.39%.
Gross Margin 100% Operating Margin -168.16% Pretax Margin -158.39% Profit Margin -158.39% EBITDA Margin -168.16% EBIT Margin -168.16% FCF Margin -112.69%
